SCHEMBL8501895

SCHEMBL8501895

O=C(c1ccc(Cl)cc1)c1c(Cl)ccc(Cn2ncccc2=O)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.40
▸ IDO1 P14902 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MITF O75030 1/20 0.39
▸ S1PR4 O95977 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ S1PR1 P21453 1/20 0.39
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ HIF1A Q16665 2/20 0.35
▸ GALR3 O60755 1/20 0.35
▸ NR2F2 P24468 1/20 0.35
▸ ADORA1 P30542 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.33
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8503193 0.84 NR4A1 (0.40) HTTIDO1ALDH1A1SMN1; SMN2MITF
SCHEMBL8502112 0.74 IDO1 (0.40) IDO1ALDH1A1SMN1; SMN2CYP3A4CYP2C9
SCHEMBL8502514 0.74 IDO1 (0.40) IDO1ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL8502103 0.74 BDKRB1 (0.37) HTTIDO1ALDH1A1TP53MAPT
SCHEMBL8504761 0.73 IDO1 (0.37) IDO1ALDH1A1SMN1; SMN2TP53MAPT
SCHEMBL8504853 0.73 KMT2A (0.49) MAPTHPGDRAB9AKMT2A
SCHEMBL8501896 0.68 NPC1 (0.38) HTTALDH1A1SMN1; SMN2MITFS1PR4
SCHEMBL8503700 0.68 POLB (0.43) HTTIDO1ALDH1A1SMN1; SMN2TP53
SCHEMBL8505614 0.68 NLRP3 (0.41) HTTIDO1ALDH1A1SMN1; SMN2TP53
SCHEMBL8502482 0.66 HPGD (0.48) ALDH1A1MAPTCYP3A4CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5886178-A ADMINISTERING OF A PROSTAGLANDIN G/H SYNTHASE INHIBITOR TO A PATIENT TO TREAT INFLAMMATORY OR AUTOIMMUNE DISEASES SYNTEX (U.S.A.) INC. (US) 1999-03-23 — — US disclosed
Send feedback